Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques?

Gelsomino, F

Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques? [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology 01 2018 - 284-286 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1569-8041

10.1093/annonc/mdx718 doi


Atherosclerosis--drug therapy
Humans
Nivolumab--therapeutic use
Plaque, Atherosclerotic--drug therapy
Programmed Cell Death 1 Receptor--antagonists & inhibitors